Leveraging three decades of global experience in Bio-pharma
A strategic advisory for all aspects of the Biopharma sector
Enabling cross-border integration in Biopharma landscape
previous arrowprevious arrow
next arrownext arrow

Innovation Focused

Creative solutions backed by solid experience and the latest industry know-how.

Global Perspective

We work with some of the largest bio-pharma companies across the globe.

Strong Network

Our extensive experience in the bio-pharma space has helped us develop a robust network of industry leaders and experts.

Our Services

The global bio-pharma industry is perpetually evolving in the search for breakthrough therapies, curative drugs, and new treatment pathways.

Bio-pharma companies are expanding both organically and inorganically to achieve better healthcare outcomes and access.

The healthcare industry is knowledge- and tech-driven, and we ensure that we are at the forefront of it all.

Our Research Services include: Therapeutic Class ResearchIndustry Themes, Perspectives


Therapeutic Class Research

New treatment pathways may sometimes entirely change the competitive landscape and other market dynamics, and hence, call for meaningful research and analysis. We provide insightful research on new therapies and their potential impacts on patient outcomes as well as company performance in order for our clients to make informed decisions in the area.

Industry Themes

As industry players work in a tireless pursuit to solve some of the most challenging puzzles, we assess interesting aspects of markets within markets, such as drivers, challenges, and competition, based on themes like drugs, patents, and filings, enabling firms to gather insights and identify rewarding opportunities.


Having been in the business of consulting our esteemed biopharma clients for decades, it gives us immense pleasure to contribute to the global knowledge pool and exert a positive influence on the advancement of this industry. We do so through our ideas and perspectives on recent events, deals, breakthrough drugs, and other themes.

Landmark Transactions

1st NCE licensed-out from India
1st Indian company acquiring major unit in the USA
Largest pharma acquisition in India
1st Indian Company making alliance with an MNC for NCE Manufacturing
1st Indian company investing in the US Biotech
Largest brand divestment by MNC in India
1st strategic entry by an Indian company in Japan through brand acquisitions
First Indian company co investing in innovation with direct MNC link
previous arrow
next arrow

Our Team

1 +
Clients Services
1 +
Companies Connections
1 +
Country Network
1 +
Reports Published

For any Questions & Inquiry

Close Menu